NIT
MDGL icon

NumerixS Investment Technologies’s Madrigal Pharmaceuticals MDGL Stock Holding History

NumerixS Investment Technologies’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-400
Closed -$27K – 1203
2020
Q1 		$27K Sell
400
-100
-20% -$8.33K 0.01% 746
2019
Q4 		$46K Buy
+500
New +$48.5K 0.01% 832
2019
Q2 		– Sell
-2,000
Closed -$252K – 1233
2019
Q1 		$252K Buy
+2,000
New +$249K 0.03% 589
2018
Q4 		– Sell
-3,250
Closed -$690K – 1252
2018
Q3 		$690K Buy
+3,250
New +$816K 0.13% 225

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

NumerixS Investment Technologies's MDGL Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2020, closing a stake of 400 shares — an estimated $27K sold.

NumerixS Investment Technologies first reported a position in MDGL in Q3 2018 and held it in 4 quarters. The position peaked at $690K in Q3 2018. 125 funds tracked by Wall St. Rank hold MDGL as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Madrigal Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 400 Madrigal Pharmaceuticals shares in Q2 2020, an estimated $27K.
  • NumerixS Investment Technologies first reported a position in Madrigal Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • NumerixS Investment Technologies's Madrigal Pharmaceuticals position peaked at $690K in Q3 2018.
  • 125 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.